aTYR PHARMA (ATYR) Shares Outstanding (2014 - 2026)

aTYR PHARMA (ATYR) has reported Shares Outstanding (Entity) for 13 consecutive years, with $98.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 5.62% year-over-year to $98.1 million; the trailing twelve-month figure through Jun 2026 stood at $98.1 million (up 5.62% YoY), and the FY2025 full-year result was $98.0 million, up 16.65% from the prior year.
• Shares Outstanding (Entity) was little changed at $98.1 million in Q2 2026 per ATYR's latest filing, from $98.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $98.1 million in Q2 2026 and bottomed at $28.1 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $67.4 million across 5 years, with a median of $72.1 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) jumped 114.54% in 2023, then gained 5.62% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $29.5 million in 2022, then jumped by 114.54% to $63.3 million in 2023, then soared by 32.79% to $84.0 million in 2024, then climbed by 16.65% to $98.0 million in 2025, then climbed by 0.06% to $98.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $98.1 million, $98.1 million, and $98.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.